{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:56:06Z","timestamp":1793922966684,"version":"4.8.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.critrevonc.2025.104837","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T12:58:13Z","timestamp":1751633893000},"page":"104837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Recent advances in tumour microenvironment impact immunotherapy resistance in gastric cancer"],"prefix":"10.1016","volume":"215","author":[{"given":"Qiuhong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.104837_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2025.04.004","article-title":"Lung tumor immunity: redirecting macrophages through infection-induced inflammation","author":"Aktay-Cetin","year":"2025","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104837_bib2","article-title":"Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting response","volume":"6","author":"Alcindor","year":"2025","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.critrevonc.2025.104837_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106008","article-title":"Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma","volume":"132","author":"Allen","year":"2022","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1384731","article-title":"Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer","volume":"15","author":"Ando","year":"2024","journal-title":"Front Pharm."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104837_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111878","article-title":"The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer","volume":"41","author":"An","year":"2022","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.47717\/turkjsurg.2024.6421","article-title":"Unveiling molecular clues: Exploring IFN\u03b3, IL-10, and MMP7 blood levels in gastric carcinoma patients","volume":"40","author":"Atul","year":"2024","journal-title":"Turk. J. Surg."},{"key":"10.1016\/j.critrevonc.2025.104837_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2025.04.027","article-title":"Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells","author":"Blidner","year":"2025","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib8","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2025.104837_bib9","article-title":"Interferon-\u03b3-stimulated antigen-presenting cancer-associated fibroblasts hinder neoadjuvant chemoimmunotherapy efficacy in lung cancer","volume":"6","author":"Cao","year":"2025"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13020-024-01032-7","article-title":"Potential of natural products and gut microbiome in tumor immunotherapy","volume":"19","author":"Cao","year":"2024","journal-title":"Chin. Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104837_bib11","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s12094-022-02777-z","article-title":"Cytokine-driven positive feedback loop organizes fibroblast transformation and facilitates gastric cancer progression","volume":"24","author":"Cao","year":"2022","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40659-025-00597-3","article-title":"Recent advances in the mechanisms of PD-L1 expression in gastric cancer: a review","volume":"58","author":"Chen","year":"2025","journal-title":"Biol. Res"},{"key":"10.1016\/j.critrevonc.2025.104837_bib13","article-title":"Crosstalk of glutamine metabolism between cancer-associated fibroblasts and cancer cells","author":"Chen","year":"2025","journal-title":"Cell Signal"},{"key":"10.1016\/j.critrevonc.2025.104837_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-025-01447-8","article-title":"Cancer-associated fibroblast-derived fibulin-5 promotes epithelial-mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosis","author":"Choi","year":"2025","journal-title":"Exp. Mol. Med"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104837_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002947","article-title":"Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma","volume":"9","author":"Deng","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104837_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009983","article-title":"SPI1+CD68+ macrophages as a biomarker for gastric cancer metastasis: a rationale for combined antiangiogenic and immunotherapy strategies","volume":"12","author":"Deng","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00430-025-00834-2","article-title":"Regulatory T cells suppress TLR9-induced formation of intrahepatic myeloid-cell aggregates for T cell population expansion in liver","volume":"214","author":"Du","year":"2025","journal-title":"Med Microbiol Immunol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1479-5876-9-140","article-title":"Combination immunotherapy and active-specific tumor cell vaccination augments anti-cancer immunity in a mouse model of gastric cancer","volume":"9","author":"van den Engel","year":"2011","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.critrevonc.2025.104837_bib19","first-page":"126","article-title":"myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment","volume":"17","author":"Fang","year":"2024"},{"key":"10.1016\/j.critrevonc.2025.104837_bib20","first-page":"1","article-title":"Immune Checkpoint Inhibitors and Immunosuppressive Tumor Microenvironment: Current Challenges and Strategies to Overcome Resistance","author":"Gill","year":"2025","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib21","article-title":"ncRNAs as Key Regulators in Gastric Cancer: From Molecular Subtyping to Therapeutic Targets","author":"Gu","year":"2025","journal-title":"Ann. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104837_bib22","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.7150\/ijbs.97091","article-title":"TRIM50 inhibits glycolysis and the malignant progression of gastric cancer by ubiquitinating PGK1","volume":"20","author":"Gu","year":"2024","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104837_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1545017","article-title":"In vitro 3D modeling of colorectal cancer: the pivotal role of the extracellular matrix, stroma and immune modulation","volume":"16","author":"Hanitrarimalala","year":"2025","journal-title":"Front Genet"},{"key":"10.1016\/j.critrevonc.2025.104837_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.808041","article-title":"TGF\u03b22 is a Prognostic Biomarker for Gastric Cancer and is Associated With Methylation and Immunotherapy Responses","volume":"13","author":"Han","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib25","article-title":"Deep learning progressive distill for predicting clinical response to conversion therapy from preoperative CT images of advanced gastric cancer patients","volume":"15","author":"Han","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.104837_bib26","article-title":"Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy","volume":"16","author":"He","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s10120-025-01621-x","article-title":"Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancer","author":"He","year":"2025","journal-title":"Gastric Cancer"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104837_bib28","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1158\/0008-5472.CAN-17-0381","article-title":"CD155T\/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer","volume":"77","author":"He","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00403-025-04237-4","article-title":"Exosomes as key mediators in immune and cancer cell interactions: insights in melanoma progression and therapy","volume":"317","author":"Hsu","year":"2025","journal-title":"Arch. Dermatol. Res"},{"key":"10.1016\/j.critrevonc.2025.104837_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molimm.2025.05.002","article-title":"Gastric cancer cells shuttle lactate to induce inflammatory CAF-like phenotype and function in bone marrow-derived mesenchymal stem cells","volume":"183","author":"Huang","year":"2025","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12876-023-03011-y","article-title":"Evaluation of clinical efficacy, adverse reactions, and safety of PD-1 inhibitors combined with chemotherapy when treating advanced gastric cancer","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s13402-025-01053-w","article-title":"High extracellular matrix stiffness upregulates TNNT1 to awaken dormant tumor cells in liver metastatic niches of gastric cancer","author":"Ji","year":"2025","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.21873\/anticanres.15510","article-title":"14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion via Matrix Metalloproteinase-1 Regulation in Human Gastric Cancer","volume":"42","author":"Jung","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2025.104837_bib34","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-24-02463","article-title":"Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction Cancer","author":"Kawakami","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110932","article-title":"TIGIT blockade increases efficacy of PD-1 blockade combined with radiation therapy in triple-negative breast cancer model","volume":"208","author":"Kim","year":"2025","journal-title":"Radio. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2300846","article-title":"Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer","volume":"16","author":"Lee","year":"2024","journal-title":"Gut Microbes"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104837_bib37","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202403019R","article-title":"Metabolic Reprogramming of Glycolysis, Lipids, and Amino Acids in Tumors: Impact on CD8+ T Cell Function and Targeted Therapeutic Strategies","volume":"39","author":"Liang","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.critrevonc.2025.104837_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2020.01.002","article-title":"Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer","volume":"128","author":"Liu","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104837_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70208","article-title":"Phase I study of BC001, a novel fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2, in advanced solid tumors","volume":"13","author":"Liu","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.critrevonc.2025.104837_bib40","article-title":"Revisiting Helicobacter pylori eradication: evolving evidence and global implications for gastric cancer prevention","author":"Liu","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2025.104837_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4009354","article-title":"Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer","volume":"2022","author":"Liu","year":"2022","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.critrevonc.2025.104837_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111475","article-title":"NSUN5 promotes tumorigenic phenotypes through the WNT signaling pathway and immunosuppression of CD8+ T cells in gastric cancer","volume":"124","author":"Liu","year":"2024","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189344","article-title":"Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment","volume":"1880","author":"Liu","year":"2025","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104837_bib44","article-title":"Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/3604935","article-title":"An On-Treatment Decreased Trend of Serum IL-6 and IL-8 as Predictive Markers Quickly Reflects Short-Term Efficacy of PD-1 Blockade Immunochemotherapy in Patients with Advanced Gastric Cancer","volume":"2024","author":"Liu","year":"2024","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.critrevonc.2025.104837_bib46","article-title":"Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104837_bib47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mc.23309","article-title":"H. pylori infection induces CXCL8 expression and promotes gastric cancer progress through downregulating KLF4","volume":"60","author":"Liu","year":"2021","journal-title":"Mol. Carcinog."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/cei\/uxad069","volume":"213","author":"Liu","year":"2023","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-025-02308-8","article-title":"SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104837_bib50","article-title":"IL-17A in gastric carcinogenesis: good or bad?","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/labmed\/lmae090","article-title":"Correlation of the abundance of MDSCs, Tregs, PD-1, and PD-L1 with the efficacy of chemotherapy and prognosis in gastric cancer","volume":"56","author":"Li","year":"2025","journal-title":"Lab Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104837_bib52","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/cr.2015.51","article-title":"Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2\/interleukin-6 signaling in the tumor microenvironment","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","article-title":"CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases","volume":"74","author":"Li","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2025.104837_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/cac2.70034","article-title":"N6-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis","author":"Li","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.critrevonc.2025.104837_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2019.10.037","article-title":"Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts","volume":"49","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104837_bib56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41419-018-0803-7","article-title":"CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6\/IL-8-arginase I axis in human gastric cancer","volume":"9","author":"Mao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib57","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1038\/s41598-025-88033-0","article-title":"Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer","volume":"15","author":"Mitsui","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104837_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001358","article-title":"Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy","volume":"8","author":"Nagaoka","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13801-1","article-title":"A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma","volume":"12","author":"Ooki","year":"2022","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104837_bib60","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/cas.14521","article-title":"Tumor microenvironment in gastric cancers","volume":"111","author":"Oya","year":"2020","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104837_bib61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12032-023-01984-0","article-title":"PI3K\/AKT\/mTOR inhibitors as potential extracellular matrix modulators for targeting EMT subtype gastric tumors","volume":"40","author":"Panneerpandian","year":"2023","journal-title":"Med Oncol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib62","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000002971","article-title":"FoxP3-positive T regulatory cells and its effector mechanisms in Crohn's disease: an immunohistochemical and image morphometric analysis on endoscopic mucosal biopsies","author":"Patra","year":"2025","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib63","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13046-022-02366-6","article-title":"A positive feedback loop between gastric cancer cells and tumor-associated macrophage induces malignancy progression","volume":"41","author":"Piao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104837_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500546","article-title":"CLDN18.2 CAR-derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer","author":"Qing","year":"2025","journal-title":"Adv. Health Mater."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12876-025-03920-0","article-title":"Unveiling the heterogeneity and immunotherapy potency of tumor-associated neutrophils in the tumor microenvironment of gastric cancer","volume":"25","author":"Qi","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.802257","article-title":"PET\/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients","volume":"11","author":"Rong","year":"2022","journal-title":"Front Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104837_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010950","article-title":"Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers","volume":"13","author":"Sacristan Santos","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib68","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/cas.14794","article-title":"Expression of asporin reprograms cancer cells to acquire resistance to oxidative stress","volume":"112","author":"Sasaki","year":"2021","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104837_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003580","article-title":"Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival","volume":"9","author":"Shah","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104837_bib70","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1158\/1078-0432.CCR-19-3920","article-title":"Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome","volume":"26","author":"Shah","year":"2020","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104837_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.139772","article-title":"Role of ITGB2 protein structure and molecular mechanism in precancerous lesions of gastric cancer: Influencing the occurrence and development of cancer through the CXCL1-CXCR2 axis","volume":"296","author":"Shang","year":"2025","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118241","article-title":"Oxidative complexity: The role of ROS in the tumor environment and therapeutic implications","volume":"127","author":"Shen","year":"2025","journal-title":"Bioorg. Med Chem."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189350","article-title":"Tumor immune microenvironment remodeling after neoadjuvant therapy in gastric cancer: Update and new challenges","volume":"1880","author":"Sun","year":"2025","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104837_bib74","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3892\/ol.2023.13960","article-title":"Efficacy and safety of PD\u20111\/PD\u2011L1 inhibitors combined with chemotherapy in patients with advanced gastric or gastro\u2011esophageal junction cancer: A systematic review and meta\u2011analysis","volume":"26","author":"Su","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2025.104837_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.70031","article-title":"Regulatory T Cells in Tumor Microenvironment: Therapeutic Approaches and Clinical Implications","author":"Sureka","year":"2025","journal-title":"Cell Biol. Int"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12935-024-03453-8","article-title":"Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1\/JAK2\/STAT3 pathway in gastric cancer","volume":"24","author":"Su","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib77","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1038\/s41467-025-58958-1","article-title":"T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers","volume":"16","author":"Tang","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104837_bib78","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1878-0261.13767","article-title":"The accumulation of myeloid-derived suppressor cells participates in abdominal infection-induced tumor progression through the PD-L1\/PD-1 axis","volume":"19","author":"Wang","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib79","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251336627","article-title":"Comparison of immune checkpoint inhibitors in combination with chemotherapy versus chemotherapy alone in the first-line treatment of advanced gastric cancer patients with low PD-L1 expression: a systematic review and meta-analysis","volume":"17","author":"Wang","year":"2025","journal-title":"Ther. Adv. Med Oncol."},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104837_bib80","article-title":"M2 Tumor-Associated Macrophages-Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.critrevonc.2025.104837_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217475","article-title":"FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity","volume":"612","author":"Wei","year":"2025","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104837_bib82","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/cancers17091492","article-title":"Association Between Epstein-Barr Virus Infection and PD-L1 Expression in Gastric Cancer: Prevalence, Clinicopathological Features, and Prognostic Implications","volume":"17","author":"Wonglhow","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104837_bib83","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3892\/mmr.2023.13014","article-title":"Astaxanthin inhibits integrin \u03b15 expression by suppressing activation of JAK1\/STAT3 in Helicobacter pylori\u2011stimulated gastric epithelial cells","volume":"27","author":"Woo","year":"2023","journal-title":"Mol. Med Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12876-025-03969-x","article-title":"Comparison of outcomes between surgery and non-surgery after conversion therapy for advanced gastric cancer with unresectable factors: a systematic review and meta-analysis","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib85","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000860","article-title":"Predictive Value of Tumor Regression Grading on the Prognosis of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Systematic Review and Meta-Analysis","author":"Wu","year":"2025","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104837_bib86","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/dna.2021.0936","article-title":"Gastric Cancer Cell-Derived Kynurenines Hyperactive Regulatory T Cells to Promote Chemoresistance via the IL-10\/STAT3\/BCL2 Signaling Pathway","volume":"41","author":"Wu","year":"2022","journal-title":"DNA Cell Biol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104837_bib87","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.7150\/thno.108817","article-title":"GPX4 knockdown suppresses M2 macrophage polarization in gastric cancer by modulating kynurenine metabolism","volume":"15","author":"Xu","year":"2025","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104837_bib88","first-page":"6040","article-title":"Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2\/MMP9-dependent manner","volume":"11","author":"Xu","year":"2019","journal-title":"Am. J. Transl. Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib89","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1038\/s41598-025-88376-8","article-title":"Identification of an extracellular matrix signature for predicting prognosis and sensitivity to therapy of patients with gastric cancer","volume":"15","author":"Xu","year":"2025","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104837_bib90","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/s41418-021-00779-y","article-title":"Mirtronic miR-4646-5p promotes gastric cancer metastasis by regulating ABHD16A and metabolite lysophosphatidylserines","volume":"28","author":"Yang","year":"2021","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib92","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10238-025-01676-1","article-title":"Cytokine profiles as predictive biomarkers for treatment outcomes in advanced gastric cancer patients undergoing PD-1 blockade immunochemotherapy: a meta-analysis","volume":"25","author":"Yang","year":"2025","journal-title":"Clin. Exp. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41419-025-07402-9","article-title":"Eliminating VEGFA+ tumor-associated neutrophils by antibody-drug conjugates boosts antitumor immunity and potentiates PD-1 immunotherapy in preclinical models of cervical cancer","volume":"16","author":"Yao","year":"2025","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104837_bib94","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1245\/s10434-024-15017-1","article-title":"Editorial Comment on: Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-\u03baB Pathway","volume":"31","author":"Yokobori","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-025-03425-w","article-title":"USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells","author":"You","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104837_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1069204","article-title":"Identification of TGF-\u03b2 signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Pharm."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104837_bib97","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1007\/s00432-023-04655-9","article-title":"Palmitic acid combined with \u03b3-interferon inhibits gastric cancer progression by modulating tumor-associated macrophages' polarization via the TLR4 pathway","volume":"149","author":"Zhang","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib98","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12967-025-06376-8","article-title":"Single-cell RNA sequencing and spatial transcriptomics reveal the heterogeneity and intercellular communication of cancer-associated fibroblasts in gastric cancer","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104837_bib99","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.18632\/aging.205434","article-title":"Ganodermanontriol regulates tumor-associated M2 macrophage polarization in gastric cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib100","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1038\/s41467-025-59878-w","article-title":"Dynamic single-cell metabolomics reveals cell-cell interaction between tumor cells and macrophages","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104837_bib101","article-title":"INHBA, transcriptionally activated by SPI1, facilitates gastric cancer progression by inducing macrophage recruitment and M2 polarization via activating the TGF-\u03b2 signaling to increase CCL2","volume":"269","author":"Zhang","year":"2025","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.critrevonc.2025.104837_bib102","article-title":"Therapeutic strategies for gastric cancer targeting immune cells: Future directions","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104837_bib103","article-title":"Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib104","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1186\/s12885-025-14261-2","article-title":"INHBA+ macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma","volume":"25","author":"Zhao","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2025.104837_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215598","article-title":"PMN-MDSCs accumulation induced by CXCL1 promotes CD8+ T cells exhaustion in gastric cancer","volume":"532","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104837_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217642","article-title":"Fibrinogen-like 2 in tumor-associated macrophage-derived extracellular vesicles shapes an immunosuppressive microenvironment in colorectal liver metastases by promoting tumor stemness and neutrophil extracellular traps formation","volume":"618","author":"Zhou","year":"2025","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104837_bib107","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3892\/ol.2021.13085","article-title":"KLK6 mediates stemness and metabolism of gastric carcinoma cells via the PI3K\/AKT\/mTOR signaling pathway","volume":"22","author":"Zhou","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2025.104837_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/jso.28136","article-title":"Modified Frailty Index Predicts Prognosis in Patients With Gastric Cancer After Gastrectomy: A Systematic Review and Meta-Analysis","author":"Zhou","year":"2025","journal-title":"J. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104837_bib109","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/CAD.0000000000001383","article-title":"Sertraline inhibits stress-induced tumor growth through regulating CD8 + T cell-mediated anti-tumor immunity","volume":"33","author":"Zhou","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104837_bib110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","article-title":"Combination strategies to maximize the benefits of cancer immunotherapy","volume":"14","author":"Zhu","year":"2021","journal-title":"J. Hematol. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:30:41Z","timestamp":1792985441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825002252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":110,"alternative-id":["S1040842825002252"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104837","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in tumour microenvironment impact immunotherapy resistance in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104837"}}